Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.

Aims: We describe the varied clinical presentations, barriers in diagnosis and outcomes of anti-HMGCR myopathy in a large national cohort.

Methods: Adults found positive for serum anti-HMGCR autoantibodies via line blot or enzyme-immunoassay followed by immunoprecipitation were included in the study.

Results: Of 75 patients identified, the records of 72 (96 %) described weakness as the presenting symptom.

Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared to European populations in Aotearoa New Zealand.

Background: In 2014 the incidence of anti-HMGCR myopathy in New Zealand was ∼1.7 case/million persons/year.

Objective: Re-estimate the population incidence and assess ethnic variation in those >40-year -olds.

Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand.

Aims: Cardiac sarcoidosis (CS) is an important cause of mortality in patients with sarcoidosis. The aim of this retrospective cohort study was to characterize the prevalence, incidence, clinical features and outcomes of CS in the southern region of New Zealand.

Methods And Results: 45 patients were identified: 23 fulfilling international classification criteria, 9 fulfilling physician consensus criteria, and 13 classified as possible CS.